1. Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
- Author
-
Mo Wang, C. Chris Yun, Yiran Han, Lei Dong, and Peijian He
- Subjects
0301 basic medicine ,Male ,Lipopolysaccharide ,RC799-869 ,RT-PCR, reverse transcriptase polymerase chain reaction ,IEC, intestinal epithelial cell ,Cell membrane ,chemistry.chemical_compound ,Transactivation ,Mice ,0302 clinical medicine ,LPA5 ,FD-4, fluorescein isothiocyanate-labeled 4 kDa dextran ,Lysophosphatidic acid ,Intestinal Mucosa ,Receptors, Lysophosphatidic Acid ,Receptor ,Original Research ,ATX, autotaxin ,IBD, inflammatory bowel disease ,Dextran Sulfate ,Gastroenterology ,Diseases of the digestive system. Gastroenterology ,GI, gastrointestinal ,Colitis ,Cell biology ,LPA ,medicine.anatomical_structure ,TJ, tight junction ,shRNA, short hairpin RNA ,LPS, lipopolysaccharide ,030211 gastroenterology & hepatology ,Signal transduction ,JAMs, junctional adhesion molecules ,Rac1 ,LPA, lysophosphatidic acid ,LPA5, LPA receptor 5 ,Barrier ,PBS, phosphate-buffered saline ,RAC1 ,ROCK, RhoA-associated kinase ,Permeability ,TER, transepithelial electrical resistance ,Cell Line ,GEF, guanine nucleotide exchange factor ,03 medical and health sciences ,Stat, signal transducers and activators of transcription ,DSS, dextran sulfate sodium ,medicine ,Animals ,Humans ,IF, immunofluorescence ,GPCR, G protein-coupled receptor ,Intestinal permeability ,Hepatology ,Stat3 ,NHE3, Na+/H+ exchanger 3 ,medicine.disease ,AJ, adherens junction ,EGFR, epidermal growth factor receptor ,Disease Models, Animal ,030104 developmental biology ,chemistry ,Caco-2 Cells ,Lysophospholipids ,SD, standard deviation - Abstract
Background & Aims Epithelial cells form a monolayer at mucosal surface that functions as a highly selective barrier. Lysophosphatidic acid (LPA) is a bioactive lipid that elicits a broad range of biological effects via cognate G protein-coupled receptors. LPA receptor 5 (LPA5) is highly expressed in intestinal epithelial cells, but its role in the intestine is not well-known. Here we determined the role of LPA5 in regulation of intestinal epithelial barrier. Methods Epithelial barrier integrity was determined in mice with intestinal epithelial cell (IEC)-specific LPA5 deletion, Lpar5ΔIEC. LPA was orally administered to mice, and intestinal permeability was measured. Dextran sulfate sodium (DSS) was used to induce colitis. Human colonic epithelial cell lines were used to determine the LPA5-mediated signaling pathways that regulate epithelial barrier. Results We observed increased epithelial permeability in Lpar5ΔIEC mice with reduced claudin-4 expression. Oral administration of LPA decreased intestinal permeability in wild-type mice, but the effect was greatly mitigated in Lpar5ΔIEC mice. Serum lipopolysaccharide level and bacterial loads in the intestine and liver were elevated in Lpar5ΔIEC mice. Lpar5ΔIEC mice developed more severe colitis induced with DSS. LPA5 transcriptionally regulated claudin-4, and this regulation was dependent on transactivation of the epidermal growth factor receptor, which induced localization of Rac1 at the cell membrane. LPA induced the translocation of Stat3 to the cell membrane and promoted the interaction between Rac1 and Stat3. Inhibition of Stat3 ablated LPA-mediated regulation of claudin-4. Conclusions This study identifies LPA5 as a regulator of the intestinal barrier. LPA5 promotes claudin-4 expression in IECs through activation of Rac1 and Stat3., Graphical abstract
- Published
- 2021